proco
Ingredients · Performance & Training

Beta-Alanine: Clinical Dose Ranges and What the Research Describes

Proco Editorial · 2026-06-04 · 6 min read

This page is educational. It describes what published research has measured about beta-alanine. It is not medical advice and does not replace consultation with a qualified healthcare professional.

Dose thresholds shown here reflect ranges used in published clinical trials, not dosing recommendations. Whether any dose is appropriate for an individual depends on factors this page cannot assess.


What beta-alanine is

Beta-alanine is a non-essential amino acid — meaning the body can synthesise it — that functions as the rate-limiting precursor to carnosine in skeletal muscle. Carnosine is a dipeptide that acts as a buffer against the accumulation of hydrogen ions (H⁺) during high-intensity exercise, which is associated with the sensation of muscular fatigue and burning during intense efforts.

Beta-alanine is notable for producing a well-known and benign sensory effect called paraesthesia — a tingling or flushing sensation on the skin — which occurs within 15–30 minutes of ingestion at doses above approximately 800 mg. This effect has been studied extensively and is not considered harmful, but it is dose-dependent and affects compliance.


The clinical dose range

Scanner database range: 3,200–6,400 mg/day, typically delivered in divided doses to reduce the intensity of paraesthesia. The most commonly studied protocol is 3,200–6,400 mg/day split into four doses of 800–1,600 mg across the day. Sustained-release formulations have been developed specifically to reduce the tingling sensation per dose.

The mechanism requires carnosine loading in muscle tissue over time — typically 4–6 weeks of consistent daily supplementation. A single pre-workout dose of beta-alanine does not produce meaningful acute carnosine loading; consistent daily use is what builds the buffer capacity that trials measure.


What trials have measured

The trial evidence for beta-alanine is concentrated in one specific domain: exercise lasting 1–4 minutes. Meta-analyses of randomised controlled trials — including a widely cited 2012 meta-analysis of 15 studies by Hobson et al. — find consistent improvements in exercise capacity and power output in efforts of this duration. Effects are smaller and less consistent for very short efforts (under 60 seconds) and are generally absent for endurance performance lasting more than 10 minutes.

Sports where the evidence base is most relevant include rowing (2,000 m races, ~6–7 minutes), cycling time trials of 2–4 minutes, sprint intervals, and repeated sprint protocols. The effect is mechanistically plausible and replicable across independent research groups, which gives the beta-alanine literature higher credibility than many sports supplement claims.

Outcomes measured across trials include total work done in time-trial tests, cycling peak power, rowing performance, and time to exhaustion at fixed intensities. The effect size in the 2012 meta-analysis was modest but statistically significant (mean improvement of approximately 2.85% in exercise capacity versus placebo).

Key limitation: Evidence is much weaker for strength-dominant sports (powerlifting, weightlifting) and for endurance sports with events lasting more than 10 minutes, where hydrogen ion accumulation is less the limiting factor.

Underdosing in commercial products

Beta-alanine is one of the most commonly underdosed ingredients in pre-workout formulas. The minimum effective daily dose in trials is 3,200 mg, yet many pre-workout products include 1,000–2,000 mg per serving. Common underdosing patterns:


Documented safety considerations

Beta-alanine's safety profile is well established. Paraesthesia — the tingling sensation — is the primary reported effect and is benign, transient, and dose-dependent. It is not an allergic reaction and does not indicate harm. It can be minimised by split dosing or using sustained-release formulations.

Long-term safety data at doses used in trials is reassuring. There are no established serious adverse effects at the studied doses. Beta-alanine is not recommended during pregnancy due to insufficient safety data in that population, in common with most supplements.


How Proco Scanner evaluates it

When the Scanner reads beta-alanine in a product, it checks whether the per-serving dose and the implied daily dose (based on recommended serving size) add up to at least 3,200 mg/day — the minimum dose used in trials showing endurance outcomes. Products with a single serving below this threshold are flagged as underdosed relative to the trial protocol.

Proco Scanner reads any supplement label and surfaces what the published research describes for each ingredient — dose, evidence quality, and known considerations. Coming to iOS. Join the waitlist for early access.

Proco provides educational, research-based information. It does not diagnose, treat, cure, or prevent any condition. Individual responses to supplementation vary based on training status, diet, health status, and other factors. If you are pregnant, breastfeeding, take prescription medication, manage a chronic condition, or are considering supplementation for a child, talk to a qualified healthcare professional before relying on any information from Proco.

If you are experiencing a medical emergency, contact your local emergency services.

Proco Scanner

Check your beta-alanine dose. Instantly.

Proco Scanner reads any supplement label and checks whether the beta-alanine dose matches what clinical trials actually used — 3,200 mg minimum daily. Coming to iOS.

Request early access No spam. We email when access opens.